Evinacumab Approval Adds a New Option for Homozygous Familial Hypercholesterolemia With a Hefty Price Tag
Bridget M. Kuehn
Abstract
price tag raises concerns about affordability.
Topics & Concepts
MedicineFamilial hypercholesterolemiaInternal medicineIntensive care medicineCholesterolLipoproteins and Cardiovascular HealthPharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life